Company Page
Psilera
Founders
Psilera is a scientist-led biopharmaceutical company founded in 2019 and headquartered in Tampa, Florida at the USF Research Park. The company develops next-generation neuroplastogens, engineering non-hallucinogenic derivatives of psychedelic compounds such as psilocybin and DMT to treat neurological and psychiatric disorders including frontotemporal dementia, alcohol use disorder, and other conditions with significant unmet medical need. Its proprietary AI-assisted drug discovery engine, Psilera Third Eye, covers over 1 million novel compounds and is designed to optimize small-molecule drug candidates at the atomic level. Psilera operates under DEA approval and has active research collaborations with the NIH, NIDA, and academic institutions.
Company Founded in 2019
Healthtech & Biotech